Protective postvaccination titers based on HCT type
| . | A . | C . | W-135 . | Y . | ||||
|---|---|---|---|---|---|---|---|---|
| N . | % . | N . | % . | N . | % . | N . | % . | |
| Autologous HCT (n = 13) | 9 | 69.2; 95% CI, 42.4-87.3 | 11 | 84.6; 95% CI, 57.8-95.7 | 9 | 69.2; 95% CI, 42.4-87.3 | 10 | 76.9; 95% CI, 49.7-91.8 |
| Allogeneic HCT (n = 54) | 45 | 83.3; 95% CI, 71.3-91.0 | 33 | 61.1; 95% CI, 47.8-73.0 | 29 | 53.7; 95% CI, 40.6-66.3 | 34 | 63.0; 95% CI, 49.6-74.6 |
| Matched-related donor (n = 15) | 13 | 86.7; 95% CI, 62.1-96.3 | 8 | 53.3; 95% CI, 30.1-75.2 | 10 | 66.7; 95% CI, 41.7-84.8 | 9 | 60.0; 95% CI, 34.7-80.2 |
| Matched-unrelated donor (n = 32) | 27 | 84.4; 95% CI, 68.2-93.1 | 21 | 65.6; 95% CI, 48.3-80.0 | 19 | 59.4; 95% CI, 42.3-74.5 | 23 | 71.9; 95% CI, 54.6-84.4 |
| Mismatched donor (n = 7) | 5 | 71.4; 95% CI, 35.9-91.8 | 4 | 57.1; 95% CI, 25.0-84.2 | 0 | 0; * | 2 | 28.6; 95% CI, 0.08-64.1 |
| . | A . | C . | W-135 . | Y . | ||||
|---|---|---|---|---|---|---|---|---|
| N . | % . | N . | % . | N . | % . | N . | % . | |
| Autologous HCT (n = 13) | 9 | 69.2; 95% CI, 42.4-87.3 | 11 | 84.6; 95% CI, 57.8-95.7 | 9 | 69.2; 95% CI, 42.4-87.3 | 10 | 76.9; 95% CI, 49.7-91.8 |
| Allogeneic HCT (n = 54) | 45 | 83.3; 95% CI, 71.3-91.0 | 33 | 61.1; 95% CI, 47.8-73.0 | 29 | 53.7; 95% CI, 40.6-66.3 | 34 | 63.0; 95% CI, 49.6-74.6 |
| Matched-related donor (n = 15) | 13 | 86.7; 95% CI, 62.1-96.3 | 8 | 53.3; 95% CI, 30.1-75.2 | 10 | 66.7; 95% CI, 41.7-84.8 | 9 | 60.0; 95% CI, 34.7-80.2 |
| Matched-unrelated donor (n = 32) | 27 | 84.4; 95% CI, 68.2-93.1 | 21 | 65.6; 95% CI, 48.3-80.0 | 19 | 59.4; 95% CI, 42.3-74.5 | 23 | 71.9; 95% CI, 54.6-84.4 |
| Mismatched donor (n = 7) | 5 | 71.4; 95% CI, 35.9-91.8 | 4 | 57.1; 95% CI, 25.0-84.2 | 0 | 0; * | 2 | 28.6; 95% CI, 0.08-64.1 |
Not calculated given the absence of vaccine responses.